ANP32B Deficiency Protects Mice From Lethal Influenza A Virus Challenge by Dampening the Host Immune Response

Sebastian Beck1, Martin Zickler1, Vinícius Pinho Dos Reis1

  • 1Viral Zoonosis - One Health, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.

Insights

Cellular factor ANP32B, not ANP32A, promotes influenza A virus (IAV) pathogenesis in mice. Targeting ANP32B offers a potential strategy against severe influenza infections.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Understanding virus-host interactions is vital for pandemic preparedness.
  • Cellular factors ANP32A and ANP32B are implicated in influenza A virus (IAV) species specificity.

Purpose of the Study:

  • To investigate the role of ANP32A and ANP32B in IAV pathogenesis using genetically modified mice.
  • To determine the impact of these cellular factors on viral tropism, immune response, and disease outcome.

Main Methods:

  • Infection of ANP32A knockout (-/-) and wild-type (+/+) mice with H3N2 and H5N1 IAV strains.
  • Infection of ANP32B knockout (-/-) and wild-type (+/+) mice with H3N2 and H5N1 IAV strains.
  • Genome-wide transcriptome analysis in ANP32B knockout and wild-type mice.

Main Results:

  • ANP32A deficiency did not significantly alter IAV tropism, immune response, or disease outcome.
  • ANP32B deficiency led to significantly reduced viral loads, inflammatory cytokine response, and pathogenicity in mice infected with H3N2 or H5N1 IAV.
  • Transcriptome analysis revealed novel immune-regulatory pathways associated with reduced pathogenicity in ANP32B-deficient mice.

Conclusions:

  • ANP32B, but not ANP32A, promotes IAV pathogenesis in a mouse model.
  • ANP32B may possess an uncharacterized immune-modulatory function during IAV infection.
  • Targeting ANP32B or its associated pathways presents a potential therapeutic strategy for severe influenza.